ArticleHuman cell2026

CBC3T-3: a novel patient-derived cisplatin-resistant distal cholangiocarcinoma cell line harboring multiple TP53 missense mutations.

Jiahui Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.